List of Tables
Table 1. Global Adult Malignant Glioma Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Adult Malignant Glioma Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Adult Malignant Glioma Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Adult Malignant Glioma Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Adult Malignant Glioma Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Adult Malignant Glioma Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Adult Malignant Glioma Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Adult Malignant Glioma Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Adult Malignant Glioma Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Adult Malignant Glioma Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adult Malignant Glioma Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Adult Malignant Glioma Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adult Malignant Glioma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Malignant Glioma Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adult Malignant Glioma Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Adult Malignant Glioma Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global Adult Malignant Glioma Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Adult Malignant Glioma Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global Adult Malignant Glioma Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Adult Malignant Glioma Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Adult Malignant Glioma Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Adult Malignant Glioma Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Adult Malignant Glioma Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Adult Malignant Glioma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Adult Malignant Glioma Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America Adult Malignant Glioma Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America Adult Malignant Glioma Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Adult Malignant Glioma Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Adult Malignant Glioma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Adult Malignant Glioma Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe Adult Malignant Glioma Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe Adult Malignant Glioma Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Adult Malignant Glioma Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Adult Malignant Glioma Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Adult Malignant Glioma Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Adult Malignant Glioma Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Adult Malignant Glioma Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Adult Malignant Glioma Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Adult Malignant Glioma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Adult Malignant Glioma Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Adult Malignant Glioma Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Adult Malignant Glioma Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Adult Malignant Glioma Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Adult Malignant Glioma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Adult Malignant Glioma Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Adult Malignant Glioma Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Adult Malignant Glioma Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Adult Malignant Glioma Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Adult Malignant Glioma Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global Adult Malignant Glioma Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global Adult Malignant Glioma Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Adult Malignant Glioma Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Adult Malignant Glioma Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Adult Malignant Glioma Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Adult Malignant Glioma Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Adult Malignant Glioma Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Adult Malignant Glioma Treatment Price (US$/Unit) by Type (2019-2024)
Table 59. Global Adult Malignant Glioma Treatment Price (US$/Unit) by Type (2025-2030)
Table 60. Global Adult Malignant Glioma Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global Adult Malignant Glioma Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global Adult Malignant Glioma Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Adult Malignant Glioma Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Adult Malignant Glioma Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Adult Malignant Glioma Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Adult Malignant Glioma Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Adult Malignant Glioma Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Adult Malignant Glioma Treatment Price (US$/Unit) by Application (2019-2024)
Table 69. Global Adult Malignant Glioma Treatment Price (US$/Unit) by Application (2025-2030)
Table 70. Merck & Co., Inc Corporation Information
Table 71. Merck & Co., Inc Description and Business Overview
Table 72. Merck & Co., Inc Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck & Co., Inc Adult Malignant Glioma Treatment Product
Table 74. Merck & Co., Inc Recent Developments/Updates
Table 75. F. Hoffmann-La Roche Ltd Corporation Information
Table 76. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 77. F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. F. Hoffmann-La Roche Ltd Adult Malignant Glioma Treatment Product
Table 79. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 80. Arbor Pharmaceuticals Corporation Information
Table 81. Arbor Pharmaceuticals Description and Business Overview
Table 82. Arbor Pharmaceuticals Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Arbor Pharmaceuticals Adult Malignant Glioma Treatment Product
Table 84. Arbor Pharmaceuticals Recent Developments/Updates
Table 85. Pfizer,Inc Corporation Information
Table 86. Pfizer,Inc Description and Business Overview
Table 87. Pfizer,Inc Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer,Inc Adult Malignant Glioma Treatment Product
Table 89. Pfizer,Inc Recent Developments/Updates
Table 90. AbbVie, Inc Corporation Information
Table 91. AbbVie, Inc Description and Business Overview
Table 92. AbbVie, Inc Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. AbbVie, Inc Adult Malignant Glioma Treatment Product
Table 94. AbbVie, Inc Recent Developments/Updates
Table 95. Amgen, Inc Corporation Information
Table 96. Amgen, Inc Description and Business Overview
Table 97. Amgen, Inc Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Amgen, Inc Adult Malignant Glioma Treatment Product
Table 99. Amgen, Inc Recent Developments/Updates
Table 100. Bristol-Myers Squibb Company Corporation Information
Table 101. Bristol-Myers Squibb Company Description and Business Overview
Table 102. Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bristol-Myers Squibb Company Adult Malignant Glioma Treatment Product
Table 104. Bristol-Myers Squibb Company Recent Developments/Updates
Table 105. Sun Pharmaceuticals Ltd Corporation Information
Table 106. Sun Pharmaceuticals Ltd Description and Business Overview
Table 107. Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sun Pharmaceuticals Ltd Adult Malignant Glioma Treatment Product
Table 109. Sun Pharmaceuticals Ltd Recent Developments/Updates
Table 110. Teva Pharmaceutical Industries Limited Corporation Information
Table 111. Teva Pharmaceutical Industries Limited Description and Business Overview
Table 112. Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Teva Pharmaceutical Industries Limited Adult Malignant Glioma Treatment Product
Table 114. Teva Pharmaceutical Industries Limited Recent Developments/Updates
Table 115. Emcure Pharmaceuticals Limited Corporation Information
Table 116. Emcure Pharmaceuticals Limited Description and Business Overview
Table 117. Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Emcure Pharmaceuticals Limited Adult Malignant Glioma Treatment Product
Table 119. Emcure Pharmaceuticals Limited Recent Developments/Updates
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Business Overview
Table 122. Bayer Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Bayer Adult Malignant Glioma Treatment Product
Table 124. Bayer Recent Developments/Updates
Table 125. SL Pharm Corporation Information
Table 126. SL Pharm Description and Business Overview
Table 127. SL Pharm Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. SL Pharm Adult Malignant Glioma Treatment Product
Table 129. SL Pharm Recent Developments/Updates
Table 130. Boan Biotech Corporation Information
Table 131. Boan Biotech Description and Business Overview
Table 132. Boan Biotech Adult Malignant Glioma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Boan Biotech Adult Malignant Glioma Treatment Product
Table 134. Boan Biotech Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Adult Malignant Glioma Treatment Distributors List
Table 138. Adult Malignant Glioma Treatment Customers List
Table 139. Adult Malignant Glioma Treatment Market Trends
Table 140. Adult Malignant Glioma Treatment Market Drivers
Table 141. Adult Malignant Glioma Treatment Market Challenges
Table 142. Adult Malignant Glioma Treatment Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Adult Malignant Glioma Treatment
Figure 2. Global Adult Malignant Glioma Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Adult Malignant Glioma Treatment Market Share by Type in 2023 & 2030
Figure 4. Chemotherapy Product Picture
Figure 5. Targeted Drug Therapy Product Picture
Figure 6. Global Adult Malignant Glioma Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Adult Malignant Glioma Treatment Market Share by Application in 2023 & 2030
Figure 8. Glioblastoma Multiforme
Figure 9. Anaplastic Astrocytoma
Figure 10. Anaplastic Oligodendroglioma
Figure 11. Anaplastic Oligoastrocytoma
Figure 12. Other
Figure 13. Global Adult Malignant Glioma Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Adult Malignant Glioma Treatment Market Size (2019-2030) & (US$ Million)
Figure 15. Global Adult Malignant Glioma Treatment Sales (2019-2030) & (K Units)
Figure 16. Global Adult Malignant Glioma Treatment Average Price (US$/Unit) & (2019-2030)
Figure 17. Adult Malignant Glioma Treatment Report Years Considered
Figure 18. Adult Malignant Glioma Treatment Sales Share by Manufacturers in 2023
Figure 19. Global Adult Malignant Glioma Treatment Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Adult Malignant Glioma Treatment Players: Market Share by Revenue in 2023
Figure 21. Adult Malignant Glioma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Adult Malignant Glioma Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Adult Malignant Glioma Treatment Sales Market Share by Country (2019-2030)
Figure 24. North America Adult Malignant Glioma Treatment Revenue Market Share by Country (2019-2030)
Figure 25. United States Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Adult Malignant Glioma Treatment Sales Market Share by Country (2019-2030)
Figure 28. Europe Adult Malignant Glioma Treatment Revenue Market Share by Country (2019-2030)
Figure 29. Germany Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Adult Malignant Glioma Treatment Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Adult Malignant Glioma Treatment Revenue Market Share by Region (2019-2030)
Figure 36. China Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Adult Malignant Glioma Treatment Sales Market Share by Country (2019-2030)
Figure 44. Latin America Adult Malignant Glioma Treatment Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Adult Malignant Glioma Treatment Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Adult Malignant Glioma Treatment Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Adult Malignant Glioma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Adult Malignant Glioma Treatment by Type (2019-2030)
Figure 54. Global Revenue Market Share of Adult Malignant Glioma Treatment by Type (2019-2030)
Figure 55. Global Adult Malignant Glioma Treatment Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Adult Malignant Glioma Treatment by Application (2019-2030)
Figure 57. Global Revenue Market Share of Adult Malignant Glioma Treatment by Application (2019-2030)
Figure 58. Global Adult Malignant Glioma Treatment Price (US$/Unit) by Application (2019-2030)
Figure 59. Adult Malignant Glioma Treatment Value Chain
Figure 60. Adult Malignant Glioma Treatment Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed